Brief: Maxcyte Gets Investigational New Drug Clearance From U.S FDA
16/07/2018 07:24
July 16 (Reuters) - MaxCyte Inc MXCT.L :
* MAXCYTE INC - RECEIVED INVESTIGATIONAL NEW DRUG (IND)
CLEARANCE
FROM US FOOD AND DRUG ADMINISTRATION (FDA) TO BEGIN A CLINICAL
STUDY IN UNITED STATES
Source text for Eikon: urn:newsml:reuters.com:*:nNDL1BmzK7
Further company coverage: MXCT.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MaxCyte
See all newsMaxCyte, Inc. MaxCyte, Inc. - MXCR - Second Price Monitoring Extn
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Price Monitoring Extension
Brief: Maxcyte And Allogene Therapeutics Sign Clinical And Commercial License Agreement To Enable The Advancement Of Allogeneic Car T (Allocar T™) Therapies
Brief: Maxcyte Signs Agreement With KSQ Therapeutics
MaxCyte, Inc. MaxCyte, Inc. - MXCR - Agreement with KSQ Therapeutics